CRISPR Therapeutics AG (CRSP): The Biotech Stock with Biggest Upside Potential
We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...
Zacks.com on MSN17h
CRISPR Therapeutics Stock Falls 34% in a Year: Time to Buy or Sell?
The fall in CRSP stock can be attributed to a lack of pipeline updates. Despite securing approval for its first marketed product in early 2024, CRSP is yet to record product sales.
Hosted on MSN2h
Cathie Wood’s ARK Investment bought 147K shares of Crispr Therapeutics today
EST Cathie Wood’s ARK Investment bought 147K shares of Crispr Therapeutics (CRSP) today Published first on TheFly – the ultimate source for ...
Chemicals from Moss Landing battery plant fire raises health concerns
Kelly Mosser, a marketing founder based in New York City, posted on social media offering to buy a new wedding dress for Los ...
As TikTok ban looms, RedNote rises—but experts warn of greater risks
Red dye No. 3 is officially banned in the United States. The announcement has raised concerns about the safety of other food ...